We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App





Abbott Demonstrates ID NOW Rapid Molecular Respiratory Testing Platform at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: ID NOW rapid molecular respiratory testing platform (Photo courtesy of Abbott)
Image: ID NOW rapid molecular respiratory testing platform (Photo courtesy of Abbott)

Abbott Diagnostics (Lake Bluff, IL, USA) is demonstrating its life-changing tests and diagnostic tools at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

At Medlab Middle East 2023, Abbott is presenting the ID NOW rapid molecular respiratory testing platform that provides real time results whenever and wherever needed in just 13 minutes or less to enhance clinical confidence and enable immediate decision-making. With a small footprint, the ID NOW platform can be placed anywhere, allowing near-patient testing or triaging for the earliest possible results. ID NOW simplifies the test process with intuitive operation, no manual pipetting and no diagnostic expertise required to perform testing. Tests are stored at room temperature and can be run on demand, right out of the box.

Abbott is also showcasing the Afinion 2 compact, rapid, multi-assay analyzer that provides valuable near patient testing at the point-of-care. With the Afinion System there’s no need to send patients to the lab or spend time tracking down their results, allowing healthcare professionals to keep their focus on the patient. In addition, Abbott is showcasing i-STAT Alinity, an easy-to-use, portable blood analyzer that delivers real-time, lab-quality diagnostic test results. i-STAT Alinity's award-winning design features a more intuitive interface that simplifies the testing process even further, allowing for minimal operator training.

Among its rapid diagnostic tests, Abbott is showcasing the Bioline HCV immunochromatographic rapid test for the qualitative detection of antibodies specific to HCV in human serum, plasma or whole blood, alongside the Bioline Influenza Antigen test which is a chromatographic immunoassay for the differential and qualitative detection of influenza virus type A and type B antigens directly from nasal / throat / nasopharyngeal swab or nasal/nasopharyngeal aspirate specimens. In addition, Abbott is presenting the Bioline RSV test, which is an immunochromatographic assay for qualitative detection of respiratory syncytial virus (RSV) in NPS (Nasopharyngeal secretion/aspirations), alongside the Bioline Strep A strip test, which is a immunochromatographic assay for the qualitative detection of group A streptococcal antigens directly from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture. Also on display at the show is i-STAT TBI Plasma test that measures the level of biomarkers associated with brain injury in the blood stream to assist in determining the need for a CT scan of the head.

Related Links:
Abbott Diagnostics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.